Mercedes Gasior

La Paz, MD, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Multidisciplinary Delphi consensus on malignancy screening in patients with common variable immunodeficiency.

Multidisciplinary Delphi consensus on malignancy screening in patients with common variable immunodeficiency.

Journal: Frontiers in immunology
Published: June 01, 2026

Survival outcomes and treatment patterns in myelofibrosis in the JAK inhibitor era.

Survival outcomes and treatment patterns in myelofibrosis in the JAK inhibitor era.

Journal: British journal of haematology
Published: May 14, 2026

Feasibility and safety profile of intranasal third-party allogeneic CD45RO+/RA- memory T cells: a phase I clinical trial (vRELEASE-I NCT06699758).

Feasibility and safety profile of intranasal third-party allogeneic CD45RO+/RA- memory T cells: a phase I clinical trial (vRELEASE-I NCT06699758).

Journal: Frontiers in medicine
Published: March 17, 2026

Coexisting Myeloproliferative and Lymphoid Neoplasms: A European Multicenter Retrospective Study.

Coexisting Myeloproliferative and Lymphoid Neoplasms: A European Multicenter Retrospective Study.

Journal: American journal of hematology
Published: June 23, 2025

Ex Vivo IL-15-Stimulated NK Cells as Adoptive Cell Therapy in Haploidentical Transplantation for Pediatric Leukemia.

Ex Vivo IL-15-Stimulated NK Cells as Adoptive Cell Therapy in Haploidentical Transplantation for Pediatric Leukemia.

Journal: American journal of hematology
Published: March 06, 2025

The phase I RELEASE clinical trial to evaluate the safety of NK cells in COVID-19.

The phase I RELEASE clinical trial to evaluate the safety of NK cells in COVID-19.

Journal: iScience
Published: June 10, 2024

DECTIN-1: A modifier protein in CTLA-4 haploinsufficiency.

DECTIN-1: A modifier protein in CTLA-4 haploinsufficiency.

Journal: Science advances
Published: December 06, 2023

Correction to: Low‑risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera.

Correction to: Low‑risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera.

Journal: Annals of hematology
Published: October 20, 2022

Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis.

Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis.

Journal: HemaSphere
Published: September 03, 2022

Predictors of thrombosis and bleeding in 1613 myelofibrosis patients from the Spanish Registry of Myelofibrosis.

Predictors of thrombosis and bleeding in 1613 myelofibrosis patients from the Spanish Registry of Myelofibrosis.

Journal: British journal of haematology
Published: July 20, 2022

Low-risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera.

Low-risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera.

Journal: Annals of hematology
Published: July 03, 2022

Low Plasma Levels of Hyaluronic Acid Might Rule Out Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation.

Low Plasma Levels of Hyaluronic Acid Might Rule Out Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation.

Journal: Disease markers
Published: May 03, 2022
Showing 1-12 of 16

Last Updated: 09/26/2026